-2.31%
Today
Loading 1D prices…
Company profile
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
Sector
Health Care
Industry
Surgical & Medical Instruments & Apparatus
Exchange
Nasdaq
Display currency
USD
Location
MALVERN, PA, United States
Employees
218
Fiscal year end
1231
CIK
1561921
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| MDAISpectral AI Inc. Class A Common Stock | $51.8M | $19.6M | -38.53% | -$0.29 | -2.41% | Buy |
| XTNTXtant Medical Holdings Inc. Common Stock | $51.4M | $133.9M | +0.00% | $0.03 | 0.00% | Buy |
| DRIODarioHealth Corp. Common Stock | $66.1M | $22.4M | -186.56% | $10.12 | -0.45% | Hold |
| CVRXCVRx Inc. Common Stock | $69.1M | $56.7M | -94.10% | -$2.04 | -6.99% | Hold |
| SRTSSensus Healthcare Inc. Common Stock | $48.2M | $27.5M | -28.09% | -$0.47 | -3.96% | Buy |